Dr. Jeremy L. Davis is a surgical oncologist whose research focus is in upper gastrointestinal tract malignancy, including stomach, pancreas and hepatobiliary cancers. He is the principal investigator for trials aimed at elucidating the drivers of metastasis in stomach cancers, including inherited forms of stomach cancer.
Jeremy L. Davis, M.D.
Dr. Jeremy L. Davis is a member of the Surgical Oncology Section of the Thoracic and Gastrointestinal Oncology Branch, NCI. His clinical research focus is in upper gastrointestinal tract malignancy. Areas of expertise include gastric cancer, including sporadic and hereditary cancers, hepato-biliary and pancreatic cancer. Dr. Davis provides standard and minimally invasive operative approaches to surgical diseases.
Phase II Trial of Heated Intraperitoneal Chemotherapy for Gastric Cancer with Positive Peritoneal CytologyOpen - RecruitingNCI Protocol ID NCI-17-C-0070Investigator Jeremy L. Davis, M.D.
Open - RecruitingNCI Protocol ID NCI-17-C-0044Investigator Jeremy L. Davis, M.D.
Hereditary Gastric Cancer SyndromesAn Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerOpen - RecruitingNCI Protocol ID NCI-17-C-0043Investigator Jeremy L. Davis, M.D.
Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid TumorsOpen - RecruitingNCI Protocol ID NCI-13-C-0176Investigator Jeremy L. Davis, M.D.
My clinical and research interests are in the treatment of gastric cancer and hepato-pancreato-biliary tumors. We manage gastric and gastroesophageal junction tumors as part of a multi-disciplinary foregut malignancy team of thoracic and general surgical oncologists and medical oncologists. Our clinical program is coordinated with the translational and basic science research efforts within TGIB.
Selected Key Publications
- Ann Surg Oncol. epub: 2016. [ Journal Article ]
β-Catenin activation in fundic gland polyps, gastric cancer and colonic polyps in families afflicted by 'gastric adenocarcinoma and proximal polyposis of the stomach' (GAPPS)..J Clin Pathol. 69(9): 826-833, 2016. [ Journal Article ]
Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review..J Surg Oncol. 115(2): 192-201, 2017. [ Journal Article ]
- Surg Clin North Am. 2017. [ Journal Article ]
- Trials. 12(1): 129, 2011. [ Journal Article ]
Dr. Davis trained in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center with an interest in gastric and hepato-pancreato-biliary tumors. He is board certified in both Complex General Surgical Oncology and General Surgery. Dr. Davis completed his surgical training at Indiana University during which time he dedicated three years as a research fellow in Surgical Oncology and Immunotherapy at NCI.
|Tatiana Beresnev||Data Manager (Contr)|
|Marcia Mulquin R.N.||Research Nurse Specialist|
|Paul Nolen C.S.T.||Patient Care Coordinator|
|Yvonne Shutack||Data Manager (Contr)|